For Healthcare Professionals / Registered Medical Practitioners Only Login | Register

PROVEN STERILITY WITHOUT AN OVERWRAP.1-5

Delivered with no extra packaging, FLEXBUMIN in the GALAXY container is designed to maintain sterility during setup and administration.1-5

DESIGNED WITH SAFETY IN MIND.1-8

Delivered in a shatterproof, flexible container, FLEXBUMIN helps reduce risk in critical situations.1-8

DESIGNED WITH EFFICIENCY IN MIND.1-3,9-10

Lightweight and flexible, the FLEXBUMIN container helps enhance storage and setup efficiencies.1-3,9-10

DESIGNED WITH ENVIRONMENTAL SUSTAINABILITY IN MIND.1-3,10-11†

Delivered in a lightweight, flexible container, FLEXBUMIN helps reduce environmental impacts throughout the product lifecycle.1-3,10-11†

PROVEN STERILITY WITHOUT AN OVERWRAP.1-5

Delivered with no extra packaging, FLEXBUMIN in the GALAXY container is designed to maintain sterility during setup and administration.1-5

DESIGNED WITH SAFETY IN MIND.1-8

Delivered in a shatterproof, flexible container, FLEXBUMIN helps reduce risk in critical situations.1-8

Lightweight and flexible, the FLEXBUMIN container helps enhance storage and setup efficiencies.1-3,9-10

DESIGNED WITH EFFICIENCY IN MIND.1-3,9-10

Delivered in a lightweight, flexible container, FLEXBUMIN helps reduce environmental impacts throughout the product lifecycle.1-3,10-11†

DESIGNED WITH ENVIRONMENTAL SUSTAINABILITY IN MIND.1-3,10-11†


 

Flexbumin Unveiled

Watch the science move

Takeda's Biolife Network

Excellence in Plasma Collection-Powering Takeda's Plasma-Based Therapies

Takeda's Albumin - Quality & Safety (Tamil Version)

Setting the Benchmark in plasma purity & safety

Takeda's Albumin - Quality & Safety (English)

Fractionation processes to minimise the risk of transmitting viruses.

Takeda's Albumin - Quality & Safety (Hindi Version)

Fractionation processes to minimise the risk of transmitting viruses.

Flexbumin Demo - Setting-up Flex Infusion

Things you should follow while handling...

Designed for Safety and Efficiency (Hindi Version)

Flexbumin it's time to change for better

Flexbumin - Designed for Safety and Efficiency

Flexbumin it's time to change for better

Flexbumin Closed System Advantage (Bengali Version)

Flexbumin it's time to change for better

Flexbumin Xperience 3D

See, explore, and understand Flexbumin in an immersive 3D journey

REFERENCES

  1. FLEXBUMIN India PI. Data on File
  2. Data on file. VV-MED-7455—FLEX-013 FLEXBUMIN biologics license application.
  3. Maki DG, Rosenthal VD, Salomao R, Franzetti F, Rangel-Frausto MS. Impact of switching from an open to a closed infusion system on rates of central line-associated bloodstream infection: a meta-analysis of time-sequence cohort studies in 4 countries. Infect Control Hosp Epidemiol. 2011;32(1):50-58.
  4. The Joint Commission. Preventing Central Line-Associated Bloodstream Infections: A Global Challenge, A Global Perspective. https://www.jointcommission.org/-/media/tjc/documents/resources/hai/clabsi_monographpdf.pdf. Accessed September 17, 2020.
  5. Kruer RM, Jarrell AS, Latif A. Reducing medication errors in critical care: a multimodal approach. Clin Pharmacol. 2014;6:117-126.
  6. van der Sluijs AF, van Slobbe-Bijlsma ER, Goossens A, Vlaar AP, Dongelmans DA. Reducing errors in the administration of medication with infusion pumps in the intensive care department: A lean approach. SAGE Open Med. 2019;7:2050312118822629.
  7. U.S. Food and Drug Administration. Safety Considerations for Product Design to Minimize Medication Errors. Guidance for Industry. https://www.fda.gov/files/drugs/published/Safety-Considerations-for-Product-Design-to-Minimize-Medication-Errors-Guidance-for-Industry.pdf. Published April 2016. Accessed May 23, 2025.
  8. Data on file VV-MED-7220—FLEX-006 Plastic vs. glass weights and dimensions.
  9. Data on file. GALAXY storage space comparisons.
  10. Data on file (No. 68128FR). GALAXY 250 mL weight comparisons. June 20, 2012.
  11. Deloitte Consulting. Final results for albumin packaged as FLEXBUMIN and BUMINATE. October 2012.

†Calculations based on BUMINATE® [Albumin (Human)], USP, 5% and 25% Solutions in glass bottles of equal volume.

Therapeutic Indication: Restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is approprite.
The choice of albumin rather then artificial colloid will depend on the clinical situation of the individual patient, based on official recommendations.

This website is intended to provide information to Healthcare Professionals and/or Registered Medical Practitioners only; it should not be used for diagnosing or treating a health problem or disease. Healthcare professionals and registered medical practitioners shall apply their independent medical judgment and patient analysis for assessing any patient and not rely on the material provided on this Website. It contains information on FLEXBUMIN®, which is based on the India Prescribing Information (PI). This website has been developed by Takeda in accordance with industry and legal standards about FLEXBUMIN®. Takeda makes every reasonable effort to include accurate and current information. However, the information provided on the website is not exhaustive. This website is not intended to be used to report adverse events or product quality complaints. If you would like to report an adverse event or product quality complaint, please contact us at AE.India@takeda.com.

This information is solely intended for the use of Registered Medical Practitioner and Hospital only. This information should not be used or shared or distributed to any other person/party and should be strictly by the intended parties for the intended purposes only.For more information please refer to full Prescribing Information

This material contains copyright protected information, content; the use of which is limited by law and this material cannot be reproduced,replicated, used or modified by any person for their own use or further distribution.

FLEXBUMIN® is trademark or registered trademark of Baxalta Incorporated. TAKEDA and the TAKEDA logo are trademarks or registered trademarks of Takeda Pharmaceutical Company Limited.

C-APROM/IN/FLEX/0286
Preparation Date: 27/May/2025

Takeda
Copyright ©2025 Takeda Pharmaceutical Company Limited. All rights reserved.

Privacy Policy

Terms of Use

Prescribing Information

Safety Information

Contact